Boronic acids have long been known to form cyclic diesters with cis-diol compounds, including many carbohydrates. This phenomenon was previously exploited to create an artificial lectin by incorporating p-borono-l-phenylalanine (Bpa) into the ligand pocket of an engineered lipocalin, resulting in a so-calledB orocalin. Here we describe the X-ray analysis of its covalentc omplex with 4-nitrocatechol as ah igh-affinity model ligand.A se xpected, the crystal structure reveals the formation of ac yclic diester between the biosynthetic boronate side chain and the two ortho-hydroxy substituents of the benzene ring. Interestingly,t he boron also has ah ydroxide ion associated, despite an only moderately basic pH 8.5 in the crystallization buffer.T he complex is stabilized by ap olar contact to the side chain of Asn134 within the ligand pocket, thus validating the functional design of the Borocalin as an artificial sugarbindingp rotein. Our structurala nalysis demonstrates how a boronate can form at hermodynamically stable diester with a vicinal diol in at etrahedral configuration in aqueous solution near physiological pH. Moreover,o ur data provide ab asis for the further engineering of the Borocalin with the goal of specific recognition of biologically relevant glycans.
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Protein-carbohydrate recognition plays af undamentalr ole in many biological processes. However,t he interactions within individual complexes are relatively weak, with dissociation constants often only in the millimolar range. [1] This generally low affinity of proteins towards sugarsc an be explained in terms of ac amouflage effect of the polyhydroxylated ligandsi nt he aqueous solvent, together with the rotational degrees of freedom of the glycosidic linkages;t hese lead to multiple conformations of an oligosaccharide [2] and, consequently,t ol oss of internal entropy upon complexf ormation.H ence, in order to mediate biologicala ctivities at low physiological concentrations, natural lectins use metal ions such as calcium, often together with the avidity effect that arises from multivalent target engagement.
On the other hand, it is well knowni nc hemistryt hat boronic acids can form covalent diesters with diol groups as they occur,i np articular, in carbohydrates. [3] Previously,w ef unctionalized human lipocalin 2( Lcn2, UniProt ID:P 80188) with ab oronic acid in its ligand pocket. Therefore, the unnaturala mino acid p-borono-l-phenylalanine (Bpa) was site-specifically incorporated at position36i nt he recombinant protein through ambers top codon suppressionb yu sing Escherichia coli cells equippedw ith an orthogonal BpaRS/tRNA UGA pair. [4] Lipocalins exhibit ar obust b-barrel fold with four structurally variable loops at the open end that form ac up-like binding site. [5] In addition to the Bpa residue, three conventional side-chain exchanges were introduced in order to enhance the steric accessibility and chemical reactivity of the boronic acid group [Lcn2(36Bpa-NFW), alias Borocalin],t hus providing ab asis for the engineering of biomedically relevant sugar specificities by employing Anticalin technology. [6] For Lcn2(36Bpa-NFW), we have demonstrated bindingo fp yranose monosaccharides, in particularg alactose and mannose, as well as of the aromatic diol 4-nitrocatechol, with dissociation constantsi nt he millimolar and micromolar ranges,respectively. [7] In its trigonal ground state, boronic acid [B(OH) 3 ,p K a % 9], with its unoccupied valence orbital, constitutes aL ewis acid that can readily react with aL ewis base such as OH À to form a tetrahedral boronate anion, such as in aqueous solution at higher pH. [8] Furthermore, cyclic diesters of boric (or boronic) acids can be formed with organic 1,2 cis-diols in at wo-step process (Scheme 1), resulting in either the trigonal or the tetrahedralc onfiguration. [3] Apart from the obvious influence of the pH on the acid/base-catalyzed addition/condensation reactions, the tetrahedral cycloadduct is usually preferred for steric reasons because its smaller OÀBÀOb ond angle leads to less ring strain. It is notablet hat 4-nitrocatechol readily forms much tighter complexes with boronic acid [8] than with pyranose sugars (see above). [7] This could be due to 1) the particular geometry of vicinal OH groups as substituents on ap lanar unsaturated carbon ring, 2) its aromatic character,a nd/or 3) the electron-withdrawing and resonance-stabilizing nitro group. [8] The first ands econd aspectc oulda ctually favor the complex in the trigonal boronate configuration, resulting in a fully planara nd p-conjugated bicyclic ring system (Scheme 1, left). To investigate whether the biosynthetic boronic acid group within the ligand pocket of the Borocalin would form a mono-o rad iesterw ith the hydroxy groups of the 4-nitrocatechol ligand and whether the latter would have at rigonal or tetrahedral configuration( Scheme 1), we elucidated the threedimensional structure of the complex. The crystal structure of the Borocalin with bound 4-nitrocatechol wass olved from an X-ray synchrotron data set at 1.98 resolution in space group C 2 ,w ith two protein molecules in the asymmetric unit, by molecular replacement with the apo-Borocalin [7] as search model.A fter refinement to af inal R factor of 20.7 % ( Table 1) , electron density was visible for the two entire polypeptide chains (residues Ser5-Lys188 in chain A, discussed below due to its lower B factors) including Bpa at position36a nd, in particular,t he covalently bound ligand ( Figure 1 ).
The protein structure of the Borocalin·ligand complex (Figure 1B)a ppearedv irtually unchanged from that of the apoprotein ( Figure 1A ). Superposition of the structurally conserved set of 58 Ca atoms in the lipocalin fold [5] led to ar oot mean square deviation (RMSD)a sl ow as 0.225 (despite ad iffering space group). The justs lightly higherR MSD of 0.445 for all 174 equivalent Ca atoms (Ser5-Gly178, without the Streptag II) [10] indicates that, beyondt he b-barrel core, the conformations of all loop segments and the a-helix werea lso conserved, including the set of those four structurally variable loops that shape the ligand pocket at the open end. [5] Only the residues of the C-terminal Strep-tag II peptide (SAWSHPQFEK) were shifted by up to 4.1 (at the Ca position), due to an intimate interaction with the neighboring molecule in the crystal lattice in the case of the apo-protein as explained in our previous study. [7] In the crystallized complex, the artificial Bpa side chain forms ac yclic diester with the 1,2-cis-diol groupso f4 -nitrocatechol, clearly visible both in the initial, ligand-free electron density andi nt he finally refined 2 F o ÀF c map, as wella sf rom a calculated omit density ( Figure 1C ). Interestingly,t he boronate anion unambiguously shows the tetrahedral configuration. Its associated hydroxidei on from the solventi se ngaged in a polar contact with the Asn134s ide chain (2.7 distance, with non-ideal H-bond angle), which appearst os tabilize the tetrahedralc onfigurationa tt he crystallization pH of 8.5 ( Figure 1C ). It is notable that this side chain is the result of as ubstitution of the originalr esidue Lys134 in wild-type Lcn2 as part of the designo ft he Borocalin. [7] The polar interaction causes as light shift of the Bpa side chain towards Asn134 in relation to the previously described structure of the ligand-free protein. [7] Moreover,t he orientation of the 4-nitrocatechol is stabilized by two hydrogen bonds formed between the side chains of Ser68 (2.2 distance) and Arg81 (2.9 distance) and the nitro group. In particular,S er68 exhibits af avorable angle geometry between its Cb and Og positions and O1 within the plane of the nitro group (in sp 2 hybridization). Notably,t he nitrocatechol ligand also makesc ontacts to the Strep-tag II at the Cterminus of as ymmetry-related protein chain that occupies the upper part of the ligand pocket.
The importance of residue Asn134 for the formation of the boronate adduct was experimentally examined by mutationo f this positiont oA la (36Bpa-AFW).T he K D value of the Borocalin containing the smaller and inert Ala side chain towards the ligand 4-nitrocatechol increased sixfold, to (29.3 AE 0.7) mm,i f compared to the Asn134 version [K D = (4.8 AE 0.04) mm in as ideby-side measurement;F igure 1D].
Our crystallographica nalysisp rovides general insight into the structure-function relationshipso fd iol recognition by boronate groups. Even thought he sugar/diol-binding activity of boric acid andits derivatives has been knownfor almost ac entury, [11] structural information on corresponding complexes has remained scarce and was mainly based on conductivity and/or spectroscopic [12] as well as NMR measurements. [13] So far,only a few X-ray structures have been elucidated for cyclic diesters between boronic acids and diol compounds:1 )a small-molecule complex between m-aminophenylboronatea nd catechol [aqua-2-(3-aminophenyl)benzo-1,3,2-dioxaborole] [9] and 2) complexes between enzymes andb oronic acid inhibitors conjugated to glycerol. [14] In the first case, the boron atom forms part of af ive-membered ring annealed to ab enzene ring. This generally leads to al ower pK a ;a lso, the hydroxylated (tetrahedral) boron configuration, with its negative charge, is intramolecu-Scheme1.pH-dependent equilibrium of Bpa, formation of amonoester,a nd furthercondensation to an entropically preferred cyclic diester with 4-nitrocatechol in either the trigonal (left) or the tetrahedral (right) configuration. Figure 1E,r ight) . In the other examples, glycerolw as added at high concentration (typically around 20 %, v/v)a scryoprotectant during protein crystal handling;h ence, glycerole ster formation in the crystal does not indicate as pecific high-affinity interaction. In fact, the crystal of the Borocalin·nitrocatechol complex had been treated with glycerolp rior to X-ray data collection in the present study,t oo;h owever, this did not lead to ad etectable ligand exchange.
Thus, the high-resolution crystal structure reported here represents the first example of as pecific cyclic diesterf ormedb etween as olvated boronic acid within the ligand pocket of a protein and a cis-diol compound in an aqueous environment (in view of as olventc ontent of 44.5 %i nt he protein crystal). The fourth boron ligand position is occupied by ah ydroxide anion, which in principle can reversibly dissociate, hence revealing stability of the tetrahedral configurationa tp H8.5 (corresponding to the crystallization buffer fort he Borocalin). Our findings shouldn ot only support the future development of boronic-acid-basedc arbohydrate ligandsw ith applicationsi n biological chemistry but also enablef urther rational reshaping of the ligand pocket of the Borocalin, eventually to obtain a high-affinity binding protein specific for medically relevant cellsurfaceglycans. 
Communications Experimental Section
For X-ray crystallographic analysis, the Borocalin (36Bpa-NFW) was expressed in E. coli and purified from the periplasmic extract by using the Strep-tag II essentially as previously described. [7] Ap rotein solution (506 mm)i n2 -(N-cyclohexylamino)ethanesulfonic acid (CHES, 20 mm)/NaOH (pH 8.5, 330 mL) was mixed at a1 :3 molar ratio with as olution of 4-nitrocatechol in water (10 mm,5 0mL) and crystallized in the presence of ammonium sulfate (1.6 m). Data for a protein crystal, flash-frozen after addition of glycerol (30 %, v/v)t o the mother liquor,w ere collected at BESSY beamline 14.1 at the Helmholtz-Zentrum Berlin, Germany,a nd processed as described. [7] After molecular replacement (see text), the covalent protein·ligand complex was refined by using BÀC( 1.610 ), BÀOC (1.520 ), and BÀOH (1.450 )b ond length parameters from ap ublished smallmolecule crystal structure. [9] The simulated annealing omit density map was calculated with PHENIX. [15] For binding studies, aH is 6 -tag was employed because in the preceding crystallographic study the C-terminal Strep-tag II had been found to fully occupy the active site of an eighboring Borocalin. [7] To this end, the Borocalin-both Lcn2(36Bpa-NFW) and the variant Lcn2(36Bpa-AFW)-was purified from the E. coli periplasmic extract by immobilized metal ion affinity chromatography (IMAC) on aH is-Trap HP column (GE Healthcare) with NaH 2 PO 4 (40 mm)/NaCl (0.5 m)a sr unning buffer (pH 7.4). The protein was eluted in a linear concentration gradient up to 300 mm imidazole/HCl. Final purification was achieved by cation exchange chromatography on aR esource Sc olumn (GE Healthcare) by using 2-morpholin-4-ylethanesulfonic acid (MES, 20 mm)/NaOH as buffer (pH 6.0) and elution with al inear concentration gradient up to 0.5 m NaCl. The binding activity for 4-nitrocatechol was determined by fluorescence titration in CHES (50 mm)/NaOH, EDTA( 1mm)p H8.5 (l ex = 280 nm, l em = 345 nm) as previously described. [7] 
